STATE OF WISCONSIN INVESTMENT BOARD - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 160 filers reported holding NEVRO CORP in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE OF WISCONSIN INVESTMENT BOARD ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2023$547,078
+112.6%
28,464
+181.1%
0.00%
+100.0%
Q2 2023$257,378
-67.5%
10,125
-53.8%
0.00%
-50.0%
Q1 2023$793,095
-6.8%
21,939
+2.1%
0.00%
-33.3%
Q4 2022$851,004
-22.4%
21,490
-8.7%
0.00%0.0%
Q3 2022$1,097,000
-2.9%
23,546
-8.7%
0.00%0.0%
Q2 2022$1,130,000
-83.1%
25,788
-72.1%
0.00%
-78.6%
Q1 2022$6,691,000
-2.9%
92,500
+8.8%
0.01%
+7.7%
Q4 2021$6,891,000
-30.3%
85,0000.0%0.01%
-35.0%
Q3 2021$9,892,000
-29.8%
85,0000.0%0.02%
-31.0%
Q2 2021$14,092,000
+18.8%
85,0000.0%0.03%
+16.0%
Q1 2021$11,857,000
-21.1%
85,000
-2.1%
0.02%
-28.6%
Q4 2020$15,025,000
+10.2%
86,800
-11.3%
0.04%
+2.9%
Q3 2020$13,637,000
+19.4%
97,900
+2.4%
0.03%
+6.2%
Q2 2020$11,421,000
+19.5%
95,6000.0%0.03%0.0%
Q1 2020$9,558,000
-14.9%
95,6000.0%0.03%
+14.3%
Q4 2019$11,237,000
+20.4%
95,600
-11.9%
0.03%
+7.7%
Q3 2019$9,333,000
-11.5%
108,567
-33.2%
0.03%
-10.3%
Q2 2019$10,541,000
+80.3%
162,590
+73.9%
0.03%
+70.6%
Q1 2019$5,845,000
+108.8%
93,500
+29.9%
0.02%
+88.9%
Q4 2018$2,800,000
-54.8%
72,000
-33.7%
0.01%
-47.1%
Q3 2018$6,190,000
-28.6%
108,6000.0%0.02%
-32.0%
Q2 2018$8,672,000
+39.0%
108,600
+50.8%
0.02%
+38.9%
Q1 2018$6,240,00072,0000.02%
Other shareholders
NEVRO CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Iron Triangle Partners LP 403,424$46,950,0006.74%
HealthCor Management, L.P. 529,230$61,592,0002.66%
Sante Capital Fund, LP 18,963$2,207,0002.04%
Jackson Square Partners, LLC 2,452,497$285,421,0001.81%
Altium Capital Management LP 51,000$5,935,0001.56%
Rock Springs Capital Management LP 635,700$73,983,0001.56%
PFM Health Sciences, LP 392,786$45,712,0001.34%
Redmile Group, LLC 542,932$63,186,0001.10%
Connacht Asset Management LP 13,555$1,578,0001.02%
Integral Health Asset Management, LLC 30,000$3,491,0001.00%
View complete list of NEVRO CORP shareholders